STOCK TITAN

Wearable Devices Receives U.S. Patent Notice of Allowance for Biometric User Authentication in Gesture and Voice-Controlled Interface Device

(Positive)
Tags

Wearable Devices (Nasdaq: WLDS) received a USPTO Notice of Allowance on April 24, 2026 for a continuation patent in its "Gesture and Voice-Controlled Interface Device" family. The allowed claims cover combining gesture sensors with biopotential sensors to authenticate users via personalized neural gesture signatures, enabling use cases like secure payments and authorized actions.

The allowance is presented as strengthening the company’s IP position and supporting applications across payments, enterprise access, AR/VR, and smart environments.

Loading...
Loading translation...

Positive

  • USPTO Notice of Allowance received on April 24, 2026
  • Claims cover combined gesture + biopotential user authentication
  • Potential enabling of secure payments and authorization use cases

Negative

  • No commercial agreements tied to the allowed claims disclosed
  • No financial impact, revenue or guidance figures provided

News Market Reaction – WLDS

+17.00%
27 alerts
+17.00% Session close to close
+19.0% Peak in 2 hr 41 min
$4.41M Market Cap
0.1x Rel. Volume

In the Apr 24 session, WLDS gained 17.00%, reflecting a significant positive market reaction. Argus tracked a peak move of +19.0% during that session. Our momentum scanner triggered 27 alerts that day, indicating elevated trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock surged +17.0% in the session following this news. A strong positive reaction aligns with t...
Analysis

The stock surged +17.0% in the session following this news. A strong positive reaction aligns with the company’s emphasis on intellectual property in neural interfaces. This patent allowance enhances protection around biometric user authentication on its Mudra platform, complementing earlier filings and commercialization efforts. However, investors have recently faced multiple registration statements and warrant-related financings that introduced dilution risk. Any large upside move would need to be evaluated alongside this existing capital structure and prior patterns of post-news weakness.

Historical Context

5 past events · Latest: Apr 20 (Negative)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Apr 20 Warrant financing Negative -13.9% Warrant inducement for $5.0M gross proceeds, highlighting further potential dilution.
Apr 20 AR partnership Positive -13.9% Collaboration with Meta-Bounds to integrate Mudra neural control into AR glasses.
Mar 16 AI advisory hires Positive -6.9% Expanded AI advisory board with ex-Google and Qualcomm executives for ai6 Labs.
Mar 12 Full-year earnings Negative -10.1% 2025 results: revenue growth but wider net loss and continued commercialization spend.
Mar 06 Reverse stock split Negative -6.5% 1-for-3 reverse split to maintain Nasdaq listing and meet minimum bid price.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent history shows frequent negative price reactions, including on arguably positive partnership and AI advisory news, suggesting a tendency for WLDS to decline around both strategic and financing announcements.

Recent Company History

Over the last several months, WLDS has reported multiple developments yet seen consistent price pressure. A 1-for-3 reverse split on Mar 11, 2026 and subsequent financings, including warrant-related registrations and a $5.0 million warrant inducement, highlighted capital needs and dilution risk. Strategic updates such as a Meta-Bounds AR glasses collaboration and expansion of the AI advisory board did not prevent declines. Today’s patent allowance adds to IP expansion, reinforcing the long-term neural interface strategy seen in earlier filings and earnings commentary.

Key Terms

biometric authentication, biological signals, biopotential sensors, neural signals, +1 more
5 terms
biometric authentication technical
"“Biometric authentication using biological signals is the natural and most secure evolution"
Biometric authentication uses a person’s unique physical or behavioral traits—such as fingerprints, facial features, iris patterns, or voice—to verify identity instead of passwords or codes. For investors, it matters because faster, more secure login methods can boost customer trust and reduce fraud-related costs, while also creating opportunities and risks around technology adoption, data privacy rules, and the companies that build or supply the biometric systems.
biological signals medical
"authenticate users from their unique biological signals, unlocking secure payments"
Biological signals are measurable signs from the body—like heart rate, brain waves, blood chemical levels or glucose readings—captured by tests or devices to show how a person or tissue is functioning. For investors, these signals are important because they drive clinical decisions, product performance data, regulatory approval and market adoption; think of them as a company’s dashboard indicators that influence risk, revenue potential and valuation in healthcare and biotech markets.
biopotential sensors medical
"combine gesture sensors with biopotential sensors to record neural signals"
Biopotential sensors are devices that pick up the tiny electrical signals produced by the body—such as heartbeats, brain activity, and muscle contractions—usually through contact with the skin or small electrodes. They matter to investors because they are the critical front end of medical monitors, diagnostic equipment and wearables: their accuracy, cost, power use and regulatory clearance directly affect product performance, market adoption and recurring revenue potential, much like a microphone must clearly capture sound before recording can be trusted.
neural signals medical
"biopotential sensors to record neural signals when the device is worn"
Neural signals are the tiny electrical and chemical impulses produced by nerve cells that carry information within the brain and between the brain and the rest of the body. For investors, these signals matter because technologies that read, interpret or change them—such as medical devices, brain‑computer interfaces, or neurological therapies—can open new markets or revenue streams and carry specific clinical, regulatory and competitive risks; think of neural signals as the body’s wiring and data streams.
gesture interface device technical
"allowed claims cover a gesture interface device and method that combine gesture"
A gesture interface device is a hardware product that detects human movements—such as hand waves, finger motions, or body positions—and translates them into commands for screens, machines, or software. Think of it as a buttonless remote that lets people control devices by moving, which can matter to investors because it can boost product appeal, create new revenue streams, and influence adoption, manufacturing costs, and competitive positioning in consumer and industrial markets.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

New continuation patent protects the ability to authenticate users from their unique biological signals, unlocking secure payments, user detection, and authorized actions

Yokneam Illit, Israel, April 24, 2026 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) (“Wearable Devices” or the “Company”), a technology growth company specializing in artificial intelligence (“AI”)-powered touchless sensing wearables, today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a new continuation patent in its foundational patent family titled “Gesture and Voice-Controlled Interface Device.”

This continuation patent application, for which Notice of Allowance has been received, is expected to significantly strengthen the Company’s intellectual property portfolio by covering technologies relating to authentication of users based on combined gesture and unique biological signals. The allowed claims cover a gesture interface device and method that combine gesture sensors with biopotential sensors to record neural signals when the device is worn. The processor analyzes sensed gestures against a personalized gesture signature and builds a gesture metric space that clusters gestures of the same user while separating different users enabling highly accurate user verification.

The technology described in the allowed claims may enable powerful new use cases such as secure payments, user detection, and authorization of sensitive actions, providing a seamless, secure, and intuitive layer of biometric protection on top of the Company’s hybrid voice-and-gesture control platform.

“Biometric authentication using biological signals is the natural and most secure evolution of our neural interface technology,” said Guy Wagner, President and Chief Scientific Officer of Wearable Devices. “By verifying not just what gesture was performed but who performed it, we are closing the security gap in touchless interfaces. This development positions our Mudra platform as a trusted solution for payments, enterprise access control, and personalized experiences in AR/VR and smart environments.”

This latest allowance continues Wearable Devices’ IP strategy, further solidifying its leadership in AI-powered neural input wearables and creating additional barriers to entry for competitors in the rapidly growing human-computer interaction market.

About Wearable Devices

Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) is a growth company pioneering human-computer interaction through its AI-powered neural input touchless technology. Leveraging proprietary sensors, software, and advanced AI algorithms, the Company’s consumer products - the Mudra Band and Mudra Link - are defining the neural input category both for wrist-worn devices and for brain-computer interfaces. These products enable touch-free, intuitive control of digital devices using gestures across multiple operating systems. Operating through a dual-channel model of direct-to-consumer sales and enterprise licensing and collaborations, Wearable Devices empowers consumers with stylish, functional wearables for enhanced experiences in gaming, productivity, and XR. In the business sector, the Company provides enterprise partners with advanced input solutions for immersive and interactive environments, from augmented reality/virtual reality/XR to smart environments. By setting the standard for neural input in the XR ecosystem, Wearable Devices is shaping the future of seamless, natural user experiences across some of the world’s fastest-growing tech markets. Wearable Devices’ ordinary shares and warrants trade on the Nasdaq Capital Market under the symbols “WLDS” and “WLDSW,” respectively.

Forward-Looking Statements Disclaimer

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be covered by the “safe harbor” created by those sections. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as “believe,” “expect,” “may,” “should,” “could,” “seek,” “intend,” “plan,” “goal,” “estimate,” “anticipate” or other comparable terms. For example, we are using forward-looking statements when we discuss the expected benefits of the allowed patent application, the potential applications of the technology, and the Company’s future growth and market opportunities. All statements other than statements of historical facts included in this press release regarding our strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: the trading of our ordinary shares or warrants and the development of a liquid trading market; our ability to successfully market our products and services; the acceptance of our products and services by customers; our continued ability to pay operating costs and ability to meet demand for our products and services; the amount and nature of competition from other security and telecom products and services; the effects of changes in the cybersecurity and telecom markets; our ability to successfully develop new products and services; our success establishing and maintaining collaborative alliance agreements, licensing and supplier arrangements; our ability to comply with applicable regulations; and the other risks and uncertainties described in our annual report on Form 20-F for the year ended December 31, 2025, filed on March 12, 2026 and our other filings with the Securities and Exchange Commission. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Investor Relations Contact:

Michal Efraty

IR@wearabledevices.co.il


FAQ

What did Wearable Devices (WLDS) announce about the April 24, 2026 patent allowance?

They announced receipt of a USPTO Notice of Allowance for a continuation patent. According to the company, the allowed claims cover combining gesture sensors with biopotential sensors to authenticate users and support secure payments and authorization use cases.

How does the allowed patent claim authenticate users on WLDS devices?

It authenticates users by comparing sensed gestures to a personalized neural gesture signature. According to the company, a processor builds a gesture metric space that clusters one user's gestures and separates different users for verification.

What use cases did Wearable Devices (WLDS) highlight for the new allowed patent?

Use cases include secure payments, user detection, and authorization of sensitive actions. According to the company, the technology adds a biometric layer to its hybrid voice-and-gesture control platform for AR/VR, enterprise access, and smart environments.

Does the April 2026 patent allowance mean immediate product rollout for WLDS?

The announcement reports strengthened IP but does not announce any immediate product launches or commercial agreements. According to the company, the allowance is intended to solidify IP and support future applications across its Mudra platform.

Will the allowed patent increase barriers to entry for WLDS competitors?

The company says the allowance is expected to strengthen its intellectual property portfolio and create additional barriers to entry. According to the company, the continued patent protection targets AI-powered neural input wearables and gesture-based biometric authentication.